// App-Quantinova.ai

9916 : Potent Antithrombotic Effect of a Small-molecule, Reversible and Direct Inhibitor of Factor XIa With Minimum Bleeding Time Effect In Rabbit Models of Arterial Thrombosis and Hemostasis

Researchers

Presenter

  • Mimi Quan

Principal Investigators

  • Carol Watson

  • Earl Crain

  • Ruth Wexler

  • Dietmar Seiffert

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Bristol-Myers Squibb

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • BMS-654457

  • Ximelagatran

  • Evithrom

Outcome

  • N/A

Study Design

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved